Systematic review: infliximab therapy in ulcerative colitis

To perform a systematic review and meta‐analysis on the efficacy and tolerance of infliximab in ulcerative colitis.

[1]  K. Murray,et al.  Infliximab for Ulcerative Colitis in Children and Adolescents , 2008, Journal of clinical gastroenterology.

[2]  C. Su.  Outcomes of placebo therapy in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[3]  W. Tremaine,et al.  American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. , 2006, Gastroenterology.

[4]  P. Rutgeerts,et al.  Review article: infliximab therapy for inflammatory bowel disease – seven years on , 2006, Alimentary pharmacology & therapeutics.

[5]  Paul Rutgeerts,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.

[6]  S. García-López,et al.  Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. , 2005, Gastroenterologia y hepatologia.

[7]  A. Hawthorne,et al.  Review article: how and when to use ciclosporin in ulcerative colitis , 2005, Alimentary pharmacology & therapeutics.

[8]  Y. Lacasse,et al.  From the authors , 2005, European Respiratory Journal.

[9]  J. Kountouras,et al.  Anti-tumor necrosis factor therapy for ulcerative colitis. , 2005, Gastroenterology.

[10]  P. Rutgeerts,et al.  A Randomized Placebo-Controlled Trial of Infliximab Therapy for Active Ulcerative Colitis: ACT I Trial Results through Week 54 , 2005 .

[11]  G. D'Haens.  Infliximab for ulcerative colitis: finally some answers. , 2005, Gastroenterology.

[12]  Å. Danielsson,et al.  Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. , 2005, Gastroenterology.

[13]  S. Hanauer,et al.  Infliximab induction and maintenance therapy for ulcerative colitis: the ACT 2 trial , 2005 .

[14]  M. Oliva-Hemker,et al.  Infliximab Efficacy in Pediatric Ulcerative Colitis , 2005, Inflammatory bowel diseases.

[15]  K. Soares-Weiser,et al.  Cyclosporine A for induction of remission in severe ulcerative colitis. , 2005, The Cochrane database of systematic reviews.

[16]  B. Göke,et al.  Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study , 2004, European journal of gastroenterology & hepatology.

[17]  K. Das,et al.  Current Therapeutic Recommendations: Infliximab for Ulcerative Colitis , 2004, Journal of clinical gastroenterology.

[18]  S. Travis.  The management of mild to severe acute ulcerative colitis , 2004, Alimentary pharmacology & therapeutics.

[19]  A. Gasbarrini,et al.  Infliximab in the treatment of steroid-dependent ulcerative colitis. , 2004, European review for medical and pharmacological sciences.

[20]  C. Prantera,et al.  Infliximab in the treatment of severe ulcerative colitis: a follow-up study. , 2004, European review for medical and pharmacological sciences.

[21]  A. Katz,et al.  Infliximab Is Effective in Acute but not Chronic Childhood Ulcerative Colitis , 2004, Journal of pediatric gastroenterology and nutrition.

[22]  S. Blanco,et al.  Infliximab como tratamiento en el brote grave de colitis ulcerosa , 2004 .

[23]  B. Göke,et al.  Safety Aspects of Infliximab in Inflammatory Bowel Disease Patients , 2004, Digestion.

[24]  M. Rizzetto,et al.  The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  K. Murray,et al.  P0593 INFLIXIMAB FOR ULCERATIVE COLITIS IN CHILDREN , 2004 .

[26]  P. Hellström,et al.  Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County , 2004, Gut.

[27]  P. Rutgeerts,et al.  Optimizing anti-TNF treatment in inflammatory bowel disease. , 2004, Gastroenterology.

[28]  P. Rutgeerts,et al.  Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis , 2004, Inflammatory bowel diseases.

[29]  I. Fuss.  Treatment of ulcerative colitis with infliximab: are we there yet? , 2004, Journal of pediatric gastroenterology and nutrition.

[30]  P. Rutgeerts,et al.  Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.

[31]  A. López-Sanromán,et al.  Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis. , 2004, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[32]  A. Forbes,et al.  Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial , 2003, Gut.

[33]  R. Modigliani,et al.  Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study , 2003, Alimentary pharmacology & therapeutics.

[34]  Louis J. Cohen,et al.  Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up , 2003, Journal of pediatric gastroenterology and nutrition.

[35]  D. Patterson,et al.  Infliximab for ulcerative colitis: Not a cure for severe disease , 2003 .

[36]  B. Iizuka,et al.  Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis , 2002, American Journal of Gastroenterology.

[37]  J. Lewis,et al.  Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis , 2002, American Journal of Gastroenterology.

[38]  C. Prantera,et al.  Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[39]  J. Achkar,et al.  Predictors of response to infliximab in patients with Crohn's disease. , 2002, Gastroenterology.

[40]  G. Actis,et al.  Infliximab for treatment of steroid-refractory ulcerative colitis. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[41]  S. Hanauer,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[42]  R. Baldassano,et al.  Infliximab as a Novel Therapy for Pediatric Ulcerative Colitis , 2002, Journal of pediatric gastroenterology and nutrition.

[43]  H. Tilg,et al.  Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. , 2001, Wiener klinische Wochenschrift.

[44]  R. J. Turner,et al.  Infliximab in the treatment of steroid-naı̈ve ulcerative colitis , 2001 .

[45]  W. Chey,et al.  Infliximab for refractory ulcerative colitis , 2001, American Journal of Gastroenterology.

[46]  A. Zinsmeister,et al.  The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. , 2001, Gastroenterology.

[47]  J. Udall,et al.  Use of Infliximab in Pediatric Patients with Inflammatory Bowel Disease , 2001, The Annals of pharmacotherapy.

[48]  W. Chey.  Infliximab for patients with refractory ulcerative colitis. , 2001, Inflammatory bowel diseases.

[49]  S. Targan,et al.  Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study , 2001, Inflammatory bowel diseases.

[50]  G. Lichtenstein.  Is infliximab effective for induction of remission in patients with ulcerative colitis? , 2001, Inflammatory bowel diseases.

[51]  Carbonnel,et al.  Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis , 2000, Alimentary pharmacology & therapeutics.

[52]  B. Vainer,et al.  Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis , 1999, American Journal of Gastroenterology.

[53]  S. V. Deventer,et al.  Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab. , 1999 .

[54]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[55]  Y. Ishiguro.  Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis , 1999, Journal of Gastroenterology.

[56]  L. Chauvelot‐Moachon,et al.  Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis , 1998, American Journal of Gastroenterology.

[57]  S. Stephens,et al.  Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. , 1997, Gut.

[58]  J. Reimund,et al.  Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease , 1996, Journal of Clinical Immunology.

[59]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[60]  R. Macdermott,et al.  Enhand secretion of tumour necrosis factor‐alpha, IL‐6, and IL‐1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease , 1993 .

[61]  M. Savage,et al.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. , 1991, Gut.

[62]  G. Järnerot,et al.  Intensive intravenous treatment of ulcerative colitis. , 1985, Gastroenterology.

[63]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .

[64]  G. Järnerot.  Infliximab or cyclosporine for severe ulcerative colitis. , 2006, Gastroenterology.

[65]  M. Siddiqui,et al.  Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis. , 2005, Drugs.

[66]  G. Rao,et al.  Infliximab in the treatment of ulcerative colitis with toxic megacolon. , 2004, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[67]  V. Orivé,et al.  [Infliximab as treatment for a severe outbreak of ulcerative colitis]. , 2004, Gastroenterologia y hepatologia.

[68]  M. Romero,et al.  Tratamiento de la colitis ulcerosa corticorrefractaria con infliximab , 2003 .

[69]  M. Castro Fernández,et al.  [Treatment of steroid-refractory ulcerative colitis with infliximab]. , 2003, Gastroenterologia y hepatologia.

[70]  G. Järnerot,et al.  Clinical evaluation and management of acute severe colitis. , 2000, Inflammatory bowel diseases.

[71]  Infliximab (Remicade) for Crohn's disease. , 1999, The Medical letter on drugs and therapeutics.

[72]  K. Mitsuyama,et al.  Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. , 1998, Scandinavian journal of gastroenterology.

[73]  S. Stephens,et al.  Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571. , 1997, Alimentary pharmacology & therapeutics.

[74]  S. Schreiber,et al.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. , 1993, Clinical and experimental immunology.

[75]  S. Truelove,et al.  Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.